Home
Journal Issues
Current Issue
In Press
Archive
Guidelines
About the journal
Author Guidelines
Peer-Review Policy
Open Access and Copyright
Author Agreement Form
Create Account
Login
Please don't use dangerous characters
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
J Renal Inj Prev
. 2018;7(1): 7-10. doi:
10.15171/jrip.2018.02
Mini-Review
Metformin; a mini-review to its antioxidative and anti-inflammatory properties
Abolfazl Abbaszadeh
1
, Sahar Koushki
2
, Shirin Koushki
2
, Marzieh Eskandarzadeh
2
, Amin Hasanvand
3
*
Cited by CrossRef: 3
1- Kluck G, Wendt C, Imperio G, Araujo M, Atella T, da Rocha I, Miranda K, Atella G. Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway.
Sci Rep
. 2019;9(1)
[Crossref]
2- Omar Z, Ahmed A, El-Bakry M, Ahmed M, Hasan A. Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride.
Annales Pharmaceutiques Françaises
. 2022;80(5):659
[Crossref]
3- Yew W, Chang K, Chan D, Zhang Y. Metformin as a host-directed therapeutic in tuberculosis: Is there a promise?.
Tuberculosis
. 2019;115:76
[Crossref]